| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) | 
|---|
| 03/11/2004 | CA2495437A1 Novel crystal | 
| 03/11/2004 | CA2495248A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases | 
| 03/11/2004 | CA2494931A1 Hetereoaryl nitrile derivatives | 
| 03/11/2004 | CA2488739A1 Nitrogen-containing aromatic derivatives | 
| 03/10/2004 | EP1396491A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors | 
| 03/10/2004 | EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives | 
| 03/10/2004 | EP1396489A1 Heteroaromatic bicyclic derivatives useful as anticancer agents | 
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof | 
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative | 
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa | 
| 03/10/2004 | EP1395592A1 Novel pyridylmethylaminopyrimidines | 
| 03/10/2004 | EP1395591A1 Corticotropin releasing factor antagonists | 
| 03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins | 
| 03/10/2004 | EP1395578A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases | 
| 03/10/2004 | EP1395577A1 Crystal forms of 6- (4-chloro-phenyl)-hydroxy-(-3-methyl-3h-imidaol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production | 
| 03/10/2004 | EP1395576A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395573A1 Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine- carboxylate -racemate | 
| 03/10/2004 | EP1395565A1 Herbicidal substituted benzoylpyrazoles | 
| 03/10/2004 | EP1395564A1 Quinoline derivatives as ligands for the neuropeptide y receptor | 
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production | 
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395556A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395555A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | 
| 03/10/2004 | EP1395261A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases | 
| 03/10/2004 | EP1334099B1 Herbicidally active pyridine sulfonyl urea derivatives | 
| 03/10/2004 | EP1021417B1 Substituted phenyluracils | 
| 03/10/2004 | CN1481382A Isoindolin-1-one glucokinase activators | 
| 03/10/2004 | CN1481381A Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use | 
| 03/10/2004 | CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists | 
| 03/10/2004 | CN1481378A Diphenyl azetidinone derivatives, method for prodn. thereof, medicaments contg. these compounds, and their use | 
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa | 
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors | 
| 03/10/2004 | CN1481369A Substituted phenyluracils compound | 
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof | 
| 03/10/2004 | CN1481365A Cyclization process step in making of quinolones and naphthyridines | 
| 03/10/2004 | CN1481361A Piperidine MCH antagonists and their use in treatment of obesity | 
| 03/10/2004 | CN1481360A 蕈毒碱拮抗剂 Muscarinic antagonist | 
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours | 
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same | 
| 03/10/2004 | CN1480451A Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative | 
| 03/10/2004 | CN1141300C Acrylonitrile compounds | 
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists | 
| 03/09/2004 | USRE38460 Huperzine A derivatives, their preparation and their use | 
| 03/09/2004 | US6703525 Antiinflammatory agents; coupling sulfonyl halide with aromatic amine compound | 
| 03/09/2004 | US6703510 More stable and durable; automotive coatings, candle wax | 
| 03/09/2004 | US6703509 Reduction of 5-arylnicotinic acids by catalytic hydrogenation in the presence of carboxylic anhydrides in which the catalyst used is a palladium/ligand complex to produce aryinicotinaldehydes | 
| 03/09/2004 | US6703403 Method for improving pharmacokinetics | 
| 03/09/2004 | US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment | 
| 03/09/2004 | US6703387 Inhibitors of HPV E1 helicase enzyme | 
| 03/09/2004 | US6703386 Treating hyperlipidemia, arteriosclerosis and hypercholesterolemia; derivatives of ezetimibe that are absorbed to a very low extent and so have a side effect reduction | 
| 03/09/2004 | US6703383 Antipsychotic sulfonamide-heterocycles, and methods of use thereof | 
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors | 
| 03/04/2004 | WO2004018486A1 Azole derivatives as antifungal agents | 
| 03/04/2004 | WO2004018485A1 Azole derivatives as antifungal agents | 
| 03/04/2004 | WO2004018463A2 Pyridyl substituted heterocycles useful for treating or preventing hcv infection | 
| 03/04/2004 | WO2004018460A1 Amino methyl imidazoles as c5a receptor modulators | 
| 03/04/2004 | WO2004018459A1 Pyrazole derivatives as gnrh inhibitors | 
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics | 
| 03/04/2004 | WO2004018457A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors | 
| 03/04/2004 | WO2004018456A1 Two-photon absorption heteroaromatic chromophores and compositions thereof | 
| 03/04/2004 | WO2004018455A1 Pyrrole based inhibitors of glycogen synthase kinase 3 | 
| 03/04/2004 | WO2004018454A1 A method for the purification of lansoprazole | 
| 03/04/2004 | WO2004018452A1 Pyrimidine derivatives as selective cox-2 inhibitors | 
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors | 
| 03/04/2004 | WO2004018450A1 Piperidine-n-oxide-derivatives | 
| 03/04/2004 | WO2004018449A1 Piperidine-derivatives as pde4 inhibitors | 
| 03/04/2004 | WO2004018438A2 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives | 
| 03/04/2004 | WO2004018437A1 5-substituted-2-arylpyrazines as modulators of crf receptors | 
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same | 
| 03/04/2004 | WO2004018435A1 Pyrimidine derivatives as modulators of chemokine receptor activity | 
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds | 
| 03/04/2004 | WO2004018433A1 Pyrimidine derivatives and their use as cb2 modulators | 
| 03/04/2004 | WO2004018431A2 Novel phenanthridines | 
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME | 
| 03/04/2004 | WO2004018428A1 Antibacterial benzoic acid derivatives | 
| 03/04/2004 | WO2004018420A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists | 
| 03/04/2004 | WO2004018419A2 Benzimidazole quinolinones and uses thereof | 
| 03/04/2004 | WO2004018418A2 Hydrophilic chemiluminescent acridinium labeling reagents | 
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods | 
| 03/04/2004 | WO2004017995A1 Preventive and/or therapeutic drugs for itch | 
| 03/04/2004 | WO2004017974A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors | 
| 03/04/2004 | WO2004017969A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion | 
| 03/04/2004 | WO2004017961A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | 
| 03/04/2004 | WO2004017917A2 Method for the prevention and/or treatment of atherosclerosis | 
| 03/04/2004 | WO2004017911A2 Protease inhibitors | 
| 03/04/2004 | WO2004005264A3 Imidazole compounds for the treatment of hepatitis c virus infections | 
| 03/04/2004 | WO2003106448A3 Nicotinoyl derivatives as herbicidal compounds | 
| 03/04/2004 | WO2003094845A3 Pyridine-based thyroid receptor ligands | 
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha | 
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands | 
| 03/04/2004 | WO2003077855A3 N3 alkylated benzimidazole derivatives as mek inhibitors | 
| 03/04/2004 | WO2003043735A3 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions | 
| 03/04/2004 | WO2002098856A3 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists | 
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease | 
| 03/04/2004 | WO2002094178A3 Treatment of renal fibrosis | 
| 03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |